Centers | ||
|
|
|
Therapeutic Accelerator Program (TAP) | Edinburgh Drug Discovery | Collaborative Drug Discovery, Inc. |
Test |
Based within the world-leading University of Edinburgh Medical School, Edinburgh Drug Discovery has a track record in successfully translating drug discovery projects from target identification through to clinical evaluation. Key areas of... |
Chemical registration system Activity & Registration - Web application within CDD Vault for chemical registration, assay data management, and SAR analysis. |
Partnerships |
Events |
Jobs |
Janssen Pharmaceuticals and Johns Hopkins To Develop New Therapies to Treat Neurological DiseasesJanssen Pharmaceuticals (Formerly OMJPI) a Johnson and Johnson entity has entered into collaboration agreement with Johns Hopkins Brain Science Institute ("BSi") at Johns Hopkins University. Janssen will be working with Johns Hopkins researchers... View all Novartis and University of Pennsylvania form Alliance in Oncology AreaUniversity of Pennsylvania and Novartis have joined hands together to start a new Center for Advanced Cellular Therapies (CACT). The new center will be based out of University of Pennsylvania campus and will be responsible to develop T Cell... View all GSK and Yale to partner on drug discovery developmentGlaxoSmithKline (GSK) and Yale University will partner to design a new class of molecules to target disease-causing proteins. This is the latest in a string of deals between Yale’s academic researchers and global pharmaceutical companies. View all |
No EVENTS for listing |
No Job Posts |
